ESC 365 - SGLT2 inhibitor for secondary prevention in acute myocardial infarction patients with diabetes mellitus

ESC Professional Premium Access

SGLT2 inhibitor for secondary prevention in acute myocardial infarction patients with diabetes mellitus

Session: Treatment of acute coronary syndromes in clinical practice

Topic: Pharmacotherapy

Speaker: Professor D. Kim (Seoul, KR)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Professor Dongbin Kim

The Catholic University of Korea, Seoul (Korea (Republic of))

1 follower

7 more presentations in this session

Effect of evolocumab on platelet function in patients with acute coronary syndromes. An analysis of the randomized, double-blind, placebo-controlled EVOPACS Trial

Speaker: Doctor K. Koskinas (Bern, CH)

ARCANGELO: an observational, prospective study with acute coronary syndrome patients undergoing percutaneous coronary intervention who receive cangrelor transitioning to oral P2Y12 inhibitors

Speaker: Doctor L. De Luca (Pavia, IT)

Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis

Speaker: Doctor S. Al Said (Boston, US)

The effect of sodium-glucose co-transporter-2 inhibitors following anterior ST-segment elevation myocardial infarction

Speaker: Doctor G. Incesu (Istanbul, TR)

Comparison of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in myocardial infarction patients with type 2 diabetes

Speaker: Doctor J. Tjerkaski (Stockholm, SE)

Access the full session

Treatment of acute coronary syndromes in clinical practice

Speakers: Professor D. Kim, Doctor K. Koskinas, Doctor L. De Luca, Doctor S. Al Said, Doctor G. Incesu...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources